» Articles » PMID: 33098655

Adverse Pathophysiological Influence of Early Testosterone Therapy on the Testes of Boys with Higher Grade Sex Chromosome Aneuploidies (HGAs): a Retrospective, Cross-sectional Study

Overview
Publisher Springer
Specialty Endocrinology
Date 2020 Oct 24
PMID 33098655
Citations 3
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: Higher grade aneuploidies (HGAs) of the male sex chromosomes are a rare genetic group of pathologies caused by nondisjunction meiotic events. The aim of this study was to evaluate the impact of early androgenic therapy on the testicular secretory hormone profile, and the pathophysiological implications.

Patients And Methods: In this cross-sectional study, 18 HGA subjects aged 6-8 years were recruited. They were divided into two groups, based on whether or not they had previously undergone testosterone therapy (group 1: 11 untreated subjects; group 2: 7 treated subjects). Serum FSH, LH, testosterone (T), inhibin B (INHB) and anti-Müllerian hormone (AMH) were determined, and auxological parameters were assessed. Five group 1 patients and four group 2 patients were treated with hCG (human chorionic gonadotropin) for inguinal cryptorchidism; their hormone profile and auxological parameters were assessed both pre- and post-hCG treatment.

Results: Group 1 subjects showed significantly higher testicular volume and higher levels of AMH and INHB (p < 0.0001). Subjects who had undergone hCG therapy showed a significantly higher testicular volume, penis length (respectively, p = 0.008 and p = 0.0005 for group 1 and p = 0.04 and p = 0.001 for group 2) and T (p = 0.005 for group 1 and p = 0.004 for group 2).

Conclusions: HGA patients undergoing early testosterone therapy show an earlier and persistent suppression of testicular secretory function. At this age, the testes are still responsive to stimulation with hCG. The selection of patients to be treated must be accompanied by a thorough clinical and hormonal evaluation.

Citing Articles

From Klinefelter Syndrome to High Grade Aneuploidies: Expanding the Gene-dosage Effect of Supernumerary X Chromosomes.

Spaziani M, Carlomagno F, Tarantino C, Angelini F, Paparella R, Tarani L J Clin Endocrinol Metab. 2024; 109(8):e1564-e1573.

PMID: 38193351 PMC: 11244175. DOI: 10.1210/clinem/dgad730.


Clinical, Cognitive and Neurodevelopmental Profile in Tetrasomies and Pentasomies: A Systematic Review.

Ricciardi G, Cammisa L, Bove R, Picchiotti G, Spaziani M, Isidori A Children (Basel). 2022; 9(11).

PMID: 36360447 PMC: 9688827. DOI: 10.3390/children9111719.


Recent advancement in the treatment of boys and adolescents with hypogonadism.

Rey R Ther Adv Endocrinol Metab. 2022; 13:20420188211065660.

PMID: 35035874 PMC: 8753232. DOI: 10.1177/20420188211065660.

References
1.
Bougneres P, Francois M, Pantalone L, Rodrigue D, Bouvattier C, Demesteere E . Effects of an early postnatal treatment of hypogonadotropic hypogonadism with a continuous subcutaneous infusion of recombinant follicle-stimulating hormone and luteinizing hormone. J Clin Endocrinol Metab. 2008; 93(6):2202-5. DOI: 10.1210/jc.2008-0121. View

2.
Radicioni A, Anzuini A, De Marco E, Nofroni I, Castracane V, Lenzi A . Changes in serum inhibin B during normal male puberty. Eur J Endocrinol. 2005; 152(3):403-9. DOI: 10.1530/eje.1.01855. View

3.
Fraccaro M, KAIJSER K, LINDSTEN J . A child with 49 chromosomes. Lancet. 1960; 2(7156):899-902. DOI: 10.1016/s0140-6736(60)91963-2. View

4.
Samango-Sprouse C, Stapleton E, Lawson P, Mitchell F, Sadeghin T, Powell S . Positive effects of early androgen therapy on the behavioral phenotype of boys with 47,XXY. Am J Med Genet C Semin Med Genet. 2015; 169(2):150-7. DOI: 10.1002/ajmg.c.31437. View

5.
Andersson A, Muller J, Skakkebaek N . Different roles of prepubertal and postpubertal germ cells and Sertoli cells in the regulation of serum inhibin B levels. J Clin Endocrinol Metab. 1998; 83(12):4451-8. DOI: 10.1210/jcem.83.12.5360. View